These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 38348044)

  • 1. Gene expression meta-analysis reveals aging and cellular senescence signatures in scleroderma-associated interstitial lung disease.
    Yang MM; Lee S; Neely J; Hinchcliff M; Wolters PJ; Sirota M
    Front Immunol; 2024; 15():1326922. PubMed ID: 38348044
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene Expression Meta-Analysis Reveals Aging and Cellular Senescence Signatures in Scleroderma-associated Interstitial Lung Disease.
    Yang MM; Lee S; Neely J; Hinchcliff M; Wolters PJ; Sirota M
    bioRxiv; 2023 Nov; ():. PubMed ID: 37986995
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integrative analysis of lung molecular signatures reveals key drivers of systemic sclerosis-associated interstitial lung disease.
    Jung SM; Park KS; Kim KJ
    Ann Rheum Dis; 2022 Jan; 81(1):108-116. PubMed ID: 34380701
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular mapping of interstitial lung disease reveals a phenotypically distinct senescent basal epithelial cell population.
    DePianto DJ; Heiden JAV; Morshead KB; Sun KH; Modrusan Z; Teng G; Wolters PJ; Arron JR
    JCI Insight; 2021 Apr; 6(8):. PubMed ID: 33705361
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disparate Interferon Signaling and Shared Aberrant Basaloid Cells in Single-Cell Profiling of Idiopathic Pulmonary Fibrosis and Systemic Sclerosis-Associated Interstitial Lung Disease.
    Valenzi E; Tabib T; Papazoglou A; Sembrat J; Trejo Bittar HE; Rojas M; Lafyatis R
    Front Immunol; 2021; 12():595811. PubMed ID: 33859634
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peripheral blood leucocyte telomere length is associated with progression of interstitial lung disease in systemic sclerosis.
    Liu S; Chung MP; Ley B; French S; Elicker BM; Fiorentino DF; Chung LS; Boin F; Wolters PJ
    Thorax; 2021 Dec; 76(12):1186-1192. PubMed ID: 34272332
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Single-cell analysis reveals fibroblast heterogeneity and myofibroblasts in systemic sclerosis-associated interstitial lung disease.
    Valenzi E; Bulik M; Tabib T; Morse C; Sembrat J; Trejo Bittar H; Rojas M; Lafyatis R
    Ann Rheum Dis; 2019 Oct; 78(10):1379-1387. PubMed ID: 31405848
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Macrophages as determinants and regulators of systemic sclerosis-related interstitial lung disease.
    Lee SC; Huang CH; Oyang YJ; Huang HC; Juan HF
    J Transl Med; 2024 Jun; 22(1):600. PubMed ID: 38937794
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Etiology, Risk Factors, and Biomarkers in Systemic Sclerosis with Interstitial Lung Disease.
    Khanna D; Tashkin DP; Denton CP; Renzoni EA; Desai SR; Varga J
    Am J Respir Crit Care Med; 2020 Mar; 201(6):650-660. PubMed ID: 31841044
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transcriptomic analyses of lung tissues reveal key genes associated with progression of systemic sclerosis-interstitial lung disease (SSc-ILD).
    Al-Adwi Y; Westra J; van Goor H; van Kempen LC; Osman M; Gan CT; Timens W; Mulder DJ
    J Autoimmun; 2024 Sep; 148():103297. PubMed ID: 39098251
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interstitial Lung Disease in Patients With Systemic Sclerosis: Toward Personalized-Medicine-Based Prediction and Drug Screening Models of Systemic Sclerosis-Related Interstitial Lung Disease (SSc-ILD).
    Khedoe P; Marges E; Hiemstra P; Ninaber M; Geelhoed M
    Front Immunol; 2020; 11():1990. PubMed ID: 33013852
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Defining genetic risk factors for scleroderma-associated interstitial lung disease : IRF5 and STAT4 gene variants are associated with scleroderma while STAT4 is protective against scleroderma-associated interstitial lung disease.
    Stock CJW; De Lauretis A; Visca D; Daccord C; Kokosi M; Kouranos V; Margaritopoulos G; George PM; Molyneaux PL; Nihtyanova S; Chua F; Maher TM; Ong V; Abraham DJ; Denton CP; Wells AU; Wain LV; Renzoni EA
    Clin Rheumatol; 2020 Apr; 39(4):1173-1179. PubMed ID: 31916109
    [TBL] [Abstract][Full Text] [Related]  

  • 13. E-Selectin, ICAM-1, and ET-1 Biomarkers Address the Concern of the Challenging Diagnosis of Interstitial Lung Disease in Patients with Autoimmune Diseases.
    Pulito-Cueto V; Remuzgo-Martínez S; Genre F; Atienza-Mateo B; Mora-Cuesta VM; Iturbe-Fernández D; Lera-Gómez L; Mora-Gil MS; Portilla V; Corrales A; Blanco R; Cifrián JM; González-Gay MA; López-Mejías R
    Int J Mol Sci; 2023 Aug; 24(15):. PubMed ID: 37569893
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulating monocytes from systemic sclerosis patients with interstitial lung disease show an enhanced profibrotic phenotype.
    Mathai SK; Gulati M; Peng X; Russell TR; Shaw AC; Rubinowitz AN; Murray LA; Siner JM; Antin-Ozerkis DE; Montgomery RR; Reilkoff RA; Bucala RJ; Herzog EL
    Lab Invest; 2010 Jun; 90(6):812-23. PubMed ID: 20404807
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-Ro52 positivity is associated with progressive interstitial lung disease in systemic sclerosis-an exploratory study.
    Hamberg V; Sohrabian A; Volkmann ER; Wildt M; Löfdahl A; Wuttge DM; Hesselstrand R; Dellgren G; Westergren-Thorsson G; Rönnelid J; Andréasson K
    Arthritis Res Ther; 2023 Sep; 25(1):162. PubMed ID: 37667402
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic predictors of systemic sclerosis-associated interstitial lung disease: a review of recent literature.
    Stock CJW; Renzoni EA
    Eur J Hum Genet; 2018 Jun; 26(6):765-777. PubMed ID: 29476163
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    He Y; Liu H; Wang S; Chen Y
    DNA Cell Biol; 2019 Sep; 38(9):933-944. PubMed ID: 31361540
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent advances in understanding the pathogenesis of scleroderma-interstitial lung disease.
    Akter T; Silver RM; Bogatkevich GS
    Curr Rheumatol Rep; 2014 Apr; 16(4):411. PubMed ID: 24523015
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High serum C-X-C motif chemokine ligand 10 (CXCL10) levels may be associated with new onset interstitial lung disease in patients with systemic sclerosis: evidence from observational, clinical, transcriptomic and in vitro studies.
    Al-Adwi Y; Atzeni IM; Doornbos-van der Meer B; van der Leij MJ; Varkevisser RDM; Kroesen BJ; Stel A; Timens W; Gan CT; van Goor H; Westra J; Mulder DJ
    EBioMedicine; 2023 Dec; 98():104883. PubMed ID: 37995465
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Netrin-1 Regulates Fibrocyte Accumulation in the Decellularized Fibrotic Sclerodermatous Lung Microenvironment and in Bleomycin-Induced Pulmonary Fibrosis.
    Sun H; Zhu Y; Pan H; Chen X; Balestrini JL; Lam TT; Kanyo JE; Eichmann A; Gulati M; Fares WH; Bai H; Feghali-Bostwick CA; Gan Y; Peng X; Moore MW; White ES; Sava P; Gonzalez AL; Cheng Y; Niklason LE; Herzog EL
    Arthritis Rheumatol; 2016 May; 68(5):1251-61. PubMed ID: 26749424
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.